Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for August 27th, 2012

« Older Entries

Prostate Cancer Savior – SMART Robotic Surgery

By on Monday, August 27th, 2012 | No Comments

$content$ http://www.youtube.com/v/PrB7M9G43vQ?version=3&f=videos&app=youtube_gdata Excerpt from: Prostate Cancer Savior – SMART Robotic Surgery

Read More...

Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT

By on Monday, August 27th, 2012 | No Comments

Conditions :   Unexplained Infertility;   Polycystic Ovarian Syndrome;   Ovulatory Dysfunction (Absence of or Irregular Ovulation With Unknown Cause) Intervention :   Drug: clomiphene citrate Sponsors :   Boston IVF;   Boston IVF;   Village Fertility Pharmacy Not yet recruiting – verified August 2012

Read More...

Lenalidomide After Failure of Hypomethylating Agents in MDS

By on Monday, August 27th, 2012 | No Comments

Condition :   Myelodysplastic Syndrome Intervention :   Drug: Lenalidomide Sponsors :   Ulsan University Hospital;   Ulsan University Hospital;   Cooperative Study Group A for Hematology Recruiting – verified August 2012

Read More...

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

By on Monday, August 27th, 2012 | No Comments

Conditions :   Autoimmune Lymphoproliferative Syndrome;   Lymphoma Intervention :   Sponsors :   National Institutes of Health Clinical Center (CC);   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting – verified August 2012

Read More...

BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

By on Monday, August 27th, 2012 | No Comments

Condition :   Early Triple Negative Breast Cancer Intervention :   Drug: Doxorubicin, Paclitaxel, Cisplatin Sponsors :   Russian Academy of Medical Sciences;   Russian Academy of Medical Sciences Recruiting – verified August 2012

Read More...

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

By on Monday, August 27th, 2012 | No Comments

Conditions :   Choledocholithiasis;   Cholangiocarcinoma;   Benign Stricture of Common Bile Duct Intervention :   Other: Blood culture ( aerobic and anaerobic) Sponsors :   Texas Tech University Health Sciences Center;   Texas Tech University Health Sciences Center;   American College of Gastroenterology Recruiting – verified August 2012

Read More...

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

By on Monday, August 27th, 2012 | No Comments

Condition :   Neurofibromatosis Intervention :   Drug: Gleevec Sponsors :   Indiana University;   Indiana University Completed – verified August 2012

Read More...

HPPH and PDT for Pleural Malignancy

By on Monday, August 27th, 2012 | No Comments

Condition :   Pleural Malignancy Intervention :   Drug: (PDT) Photodynamic therapy Sponsors :   Abramson Cancer Center of the University of Pennsylvania;   Abramson Cancer Center of the University of Pennsylvania Recruiting – verified August 2012

Read More...

At-Home Group Video Calling in Improving Quality of Life in Rural Patients With Breast Cancer

By on Monday, August 27th, 2012 | No Comments

Conditions :   Cancer Survivor;   Depression;   Post-traumatic Stress Disorder;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer Interventions :   Procedure: support group therapy;   Other: educational intervention;   Other: questionnaire administration;   Procedure: quality-of-life assessment Sponsors :   Stanford University;   Stanford University;   National Cancer Institute (NCI) Not yet recruiting – verified August 2012

Read More...

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

By on Monday, August 27th, 2012 | No Comments

Conditions :   Carcinoma, Renal Cell;   Renal Cell Carcinoma With Clear Cell Histology;   Renal Cell Carcinoma With Non-Clear Cell Histology;   Renal Cell Carcinoma of Papillary Histology Intervention :   Drug: AGS-16C3F Sponsors :   Astellas Pharma Inc;   Agensys, Inc. Recruiting – verified August 2012

Read More...
« Older Entries